Health Catalyst, Inc.
Health Catalyst, Inc. (HCAT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · HCAT · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
3
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Health Catalyst, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
HCAT insider buying and selling by quarter
HCAT insider selling · HCAT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · HCAT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
HCAT executive sell shares · HCAT board member insider trading · HCAT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | Albert Benjamin CEO · Director | Other | 336 | $460 | Form 4 |
| Jun 1, 2026 | Llewelyn Linda CPO | Other | 8,519 | $12K | Form 4 |
| Jun 1, 2026 | Alger Jason CFO | Other | 18,804 | $26K | Form 4 |
| Jun 1, 2026 | Landry Benjamin General Counsel | Other | 13,779 | $19K | Form 4 |
| Jun 1, 2026 | Larson-Green Julie Director | Award | 12,710 | — | Form 4 |
| May 1, 2026 | Nelson Steven H Director | Award | 154,808 | — | Form 4 |
| Apr 29, 2026 | Albert Benjamin CEO · Director | Award | 1,124 | — | Form 4 |
| May 1, 2026 | Albert Benjamin CEO · Director | Other | 310 | $417 | Form 4 |
| Mar 10, 2026 | Albert Benjamin CEO · Director | Other | 70,455 | $130K | Form 4 |
| Mar 2, 2026 | Landry Benjamin General Counsel | Other | 20,838 | $35K | Form 4 |
| Mar 2, 2026 | Alger Jason CFO | Other | 26,970 | $45K | Form 4 |
| Mar 2, 2026 | Albert Benjamin CEO · Director | Other | 4,966 | $8K | Form 4 |
| Mar 1, 2026 | Larson-Green Julie Director | Award | 8,361 | — | Form 4 |
| Mar 2, 2026 | Llewelyn Linda CPO | Other | 13,836 | $23K | Form 4 |
| Feb 25, 2026 | Albert Benjamin CEO · Director | Award | 38,833 | — | Form 4 |
| Feb 26, 2026 | Albert Benjamin CEO · Director | Other | 13,304 | $23K | Form 4 |
| Feb 25, 2026 | Albert Benjamin CEO · Director | Award | 930,000 | — | Form 4 |
| Feb 25, 2026 | Llewelyn Linda CPO | Award | 13,195 | — | Form 4 |
| Feb 26, 2026 | Llewelyn Linda CPO | Other | 4,471 | $8K | Form 4 |
| Feb 25, 2026 | Llewelyn Linda CPO | Award | 191,500 | — | Form 4 |
| Feb 25, 2026 | Landry Benjamin General Counsel | Award | 16,473 | — | Form 4 |
| Feb 26, 2026 | Landry Benjamin General Counsel | Other | 6,317 | $11K | Form 4 |
| Feb 25, 2026 | Landry Benjamin General Counsel | Award | 289,000 | — | Form 4 |
| Feb 25, 2026 | Alger Jason CFO | Award | 22,222 | — | Form 4 |
| Feb 26, 2026 | Alger Jason CFO | Other | 7,522 | $13K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About HCAT insider trading
HCAT insider trades
Health Catalyst, Inc. (HCAT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Albert Benjamin (CEO · Director), Landry Benjamin (General Counsel), Llewelyn Linda (CPO). Over the past 12 months, 5 insiders have filed transactions with the SEC. HCAT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Health Catalyst, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
HCAT insider trading · 5 questionsThe insiders of Health Catalyst, Inc. (HCAT) include executives and directors such as Albert Benjamin (CEO · Director), Landry Benjamin (General Counsel), Llewelyn Linda (CPO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026